New data for investigational nipocalimab in Sjögren's Disease (SjD) and new research on the impact of TREMFYA® (guselkumab) in psoriatic arthritis (PsA) will be highlighted across three oral sessions ...
Researchers explored the relationships between neighborhood-level environmental and social vulnerabilities and fragmented care among patients with rheumatic conditions.